Market Signal Briefing

India's Adani Group plans to invest up to $5 billion in Alphabet-owned Google's India AI data centre project, an executive said on Friday, as it seeks to cash in on booming demand for data capacity in the world's most populous nation.

NEW YORK, NY / ACCESS Newswire / November 28, 2025 / Dubai has spent years building the most sophisticated commodity ecosystem in the Middle East, but the real shift did not happen with new free zones or massive logistics hubs. It happened when the DMCC began redefining itself as the global center of material verification.

Malcolm Ethridge, Managing Partner at Capital Area Planning Group, joins CNBC's Halftime Report to explain why he's buying more Zscaler here.

November 28, 2025 11:30 ET

 | Source:

Global-e Online Ltd

PETACH TIKVAH, Israel, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Global-e (Nasdaq: GLBE), the platform powering global direct-to-consumer e-commerce, today announced that it will participate in the following conferences in December 2025:

UBS’s Global Technology and AI Conference 2025

On December 2 & 3, 2025, Amir Schlachet (Co-Founder & CEO), Ofer Koren (CFO), and Alan Katz (Vice President, Investor Relations) will participate in investor meetings and a fireside chatFireside chat details: December 3, 2025 at 9:35am ET. A Webcast and replay of the event will be available on the “News & Events” section of the company’s IR website at https://investors.global-e.com/ Raymond James’s 2025 TMT and Consumer Conference

On December 8, 2025, Alan Katz (Vice President, Investor Relations) will participate in investor meetings
About Global-e

Global-e (Nasdaq: GLBE) is the world's leading platform enabling and accelerating global, Direct-To-Consumer e-commerce. The chosen partner of over 1,400 brands and retailers across North America, EMEA and APAC, Global-e makes selling internationally as simple as selling domestically. The company enables merchants to increase the conversion of international traffic into sales by offering online shoppers in over 200 destinations worldwide a seamless, localized shopping experience. Global-e's end-to-end e-commerce solutions combine best-in-class localization capabilities, big-data best-practice business intelligence models, streamlined international logistics and vast global e-commerce experience, enabling international shoppers to buy seamlessly online and retailers to sell to, and from, anywhere in the world. For more information, please visit: www.global-e.com.

Global-e Media Contact
Sarah Schloss
Headline Media
[email protected]
+1 914 506 5104

Global-e Investor Contact
Alan Katz
Vice President, Investor Relations
[email protected]

, /PRNewswire/ -- CIMG Inc. ("CIMG" or the "Company") (Nasdaq: IMG), a business group specializing in digital health and sales development, which utilizes technology and marketing to enhance its business partners' sales growth and commercial value, today announced that its tokenized stock, which it previously announced was authorized for issuance on the FlowStocks platform, has completed testing and has be officially launched for public trading on November 28.

The trading symbol for CIMG stock on FlowStocks is tIMG.

Starting November 28, 2025, CIMG shareholders will be able to tokenize their shares on FlowStocks, while the public can also purchase and transfer tIMG by depositing funds into their FlowStocks wallets.

Deposit instructions for the FlowStocks platform are as follows:

Click the menu bar in the upper right corner of the FlowStocks page, select 【Connect Wallet】, and connect a commonly used wallet (e.g., MetaMask, OKX Wallet, etc.).
Go to the product purchase page and click Deposit, or select 【My Assets】→【Deposit】 from the menu bar. Choose the currency for deposit, enter the amount, and authorize the payment.
After the transaction is submitted successfully, wait for on-chain confirmation.
Return to the 【My Assets】 page to view your deposit history.

Clarification on Underlying Assets:

A total of 15,000,000 shares of CIMG—corresponding to this tokenization—have been fully transferred into FlowStocks Special Purpose Vehicle (SPV) and duly registered under the Transfer Agent (TA) system. These shares have been tokenized on-chain at a 1:1 ratio and minted as tIMG tokens, serving as the underlying asset backing for the token.

In the initial phase of the tIMG launch, CIMG and FlowStocks will jointly introduce incentive programs for purchasing tIMG, such as token rewards for users who reach certain deposit or purchase thresholds.

Alice Wang, Chairwoman and Chief Executive Officer of CIMG, stated, "We believe that stock tokenization is becoming a trend. It enables round-the-clock access to tokenized equity trading. By introducing tokenization, we are not only upgrading our financial infrastructure but also aiming to provide greater convenience for our investors."

About CIMG Inc.

CIMG Inc. is a global business group in the digital health industry, built around cryptocurrency strategies. The company leverages AI and cryptocurrencies (such as Bitcoin and stablecoins) to drive industry growth, helping clients maximize user acquisition and brand management value. Its current portfolio includes brands like Kangduoyuan, Maca-Noni, Qianmao, Huomao, and Coco-mango.

Forward-Looking Statements

This press release contains information about the Company's view of its future expectations, plans and prospects that constitute forward-looking statements. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets into its portfolio of products and services, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the technical skills and experience necessary for its operations, and its ability to protect its intellectual property. There cannot be any assurance that the Company and Flock well enter into a definitive agreement. The Company encourages you to review other factors that may affect its future results in the Company's annual reports and in its other filings with the Securities and Exchange Commission.

For more information, please contact:

http://www.ccmg.tech 

[email protected]

SOURCE CIMG Inc.

November 28, 2025 11:34 AM EST | Source: Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In CarMax To Contact Him Directly To Discuss Their Options

If you suffered losses in CarMax between June 20, 2025 and September 24, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

New York, New York--(Newsfile Corp. - November 28, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against CarMax, Inc. ("CarMax" or the "Company") (NYSE: KMX) and reminds investors of the January 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Defendants recklessly overstated CarMax's growth prospects when, in reality, its earlier growth in the 2026 fiscal year was a temporary benefit from customers buying cars due to speculation regarding tariffs; and (2) as a result, defendants statements about CarMax's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

On September 25, 2025, the Company released its second quarter fiscal 2026 financial results, disclosing that "[CarMax Auto Finance, or CAF] income decreased 11.2%" due to a $142.2 million provision for loan losses in the second quarter of fiscal 2026 compared to $112.6 million in the prior year's second quarter. Further, the Company stated that "[t]he provision for loan losses in the second quarter of 2026 included an increase of $71.3 million in our estimate of lifetime losses on existing loans, primarily due to worsening performance among the 2022 and 2023 vintages" and that "[t]he remaining $70.9 million reflected our estimate of lifetime losses on current quarter originations."

Following this news, the price of CarMax stock fell $11.45 per share, approximately 20%, to close at $45.60 per share on September 26, 2025.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding CarMax's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the CarMax class action, go to www.faruqilaw.com/KMX or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/275741

November 28, 2025 11:41 ET

 | Source:

Shell plc

Total Voting Rights

In conformity with the Disclosure Guidance and Transparency Rules, we hereby notify the market of the following:

Shell plc's capital as at November 28, 2025, consists of 5,750,420,233 ordinary shares of €0.07 each. Shell plc holds no shares in Treasury.

The figure, 5,750,420,233, may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Shell plc under the FCA's Disclosure Guidance and Transparency Rules.

Note: This announcement is made pursuant to Disclosure Guidance and Transparency Rule 5.6.1 and as such, the above figure includes shares purchased by Shell plc as part of its share buy-back programme but not yet cancelled.

Enquiries

Shell Media Relations
International +44 (0)207 934 5550; U.S. and Canada: Contact form

NEW YORK--(BUSINESS WIRE)-- #BlackFriday--Luvme Hair, a trusted brand in colored human hair wigs and innovative glueless lace wigs, is proud to announce its 2025 Last Black Friday Carnival. This exclusive event features up to $130 off select wig collections for 72 hours only, giving customers a rare opportunity to refresh their look with premium styles at exceptional prices. Whether you're seeking a hassle-free, natural appearance with lace wigs or exploring vibrant new colors, Luvme Hair's high-quality produ.

NEW YORK, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Telix Pharmaceuticals Limited (NASDAQ:TLX) and Firefly Aerospace Inc. (NASDAQ:FLY). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Telix Pharmaceuticals Limited (NASDAQ:TLX)

Class Period: February 21, 2025 to August 28, 2025
Lead Plaintiff Deadline: January 9, 2026
According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Defendants materially overstated the progress Telix had made with regard to prostate cancer therapeutic candidates; (2) Defendants materials overstated the quality of Telix’s supply chain and partners; and (3) as a result, defendants statements about Telix’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.For more information on the Telix lawsuit go to: https://bespc.com/cases/TLX
Firefly Aerospace Inc. (NASDAQ:FLY)

Firefly common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company’s initial public offering conducted on or about August 7, 2025 (the “IPO” or “Offering”); and/or Firefly securities between August 7, 2025 and September 29, 2025.
Lead Plaintiff Deadline: January 12, 2026
According to the complaint, the Offering Documents issued in connection with the Company's IPO were negligently prepared. Specifically, during the class period, the Offering Documents and defendants failed to disclose that: (i) Firefly had overstated the demand and growth prospects for its Spacecraft Solutions offerings; (ii) Firefly had overstated the operational readiness and commercial viability of its Alpha rocket program; and (iii) the foregoing, once revealed, would likely have a material negative impact on the Company.Plaintiff alleges that on September 22, 2025, Firefly reported disappointing financial results for the second quarter of 2025. On this news, Firefly's stock price fell $7.58 per share, or 15.31%, to close at $41.94 per share on September 23, 2025.  Then, on September 29, 2025, Firefly disclosed that "the first stage of Firefly's Alpha Flight 7 rocket experienced an event that resulted in a loss of the stage."  On this news, Firefly's stock price fell $7.66 per share, or 20.73%, to close at $29.30 per share on September 30, 2025. As of the time the complaint was filed, Firefly's stock price continues to trade significantly below the $45.00 per share Offering price, damaging investors.For more information on the Firefly class action go to: https://bespc.com/cases/FLY
About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities,
derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation. The firm has a nationwide practice and routinely handles cases in both federal and state courts. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
(212) 355-4648
[email protected]
www.bespc.com

NEW YORK, NY / ACCESS Newswire / November 28, 2025 / The rare earth industry has spent years circling the same problem. Minerals move through too many borders, too many processors, and too many chemical transformations to maintain a trustworthy origin story.

Analyst’s Disclosure:I/we have a beneficial long position in the shares of SLB either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

This is not advice to buy or sell this stock or ETF, despite the particular rating I am required to select in the SA template. I am not an accountant, CPA, or CFA. This article is intended to provide information to interested parties and is in no way a recommendation to buy or sell the securities mentioned. As I have no knowledge of individual investor circumstances, goals, and/or portfolio concentration or diversification, readers are expected to do their own due diligence before investing their hard-earned cash.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

, /PRNewswire/ --

Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Alexandria Real Estate Equities, Inc. (NYSE: ARE) between January 27, 2025 and October 27, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 26, 2026.

So what: If you purchased Alexandria Real Estate Equities securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Alexandria Real Estate Equities class action, go to https://rosenlegal.com/submit-form/?case_id=48531 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 26, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, defendants provided investors with material information concerning Alexandria Real Estate's expected revenue and funds from operations ("FFO") growth for the 2025 fiscal year, particularly as it related to the growth of Alexandria Real Estate's real estate operations. The defendants' statements included, among other things, confidence in Alexandria Real Estate Equities' lease activity, occupancy stability, and ability to develop its tenant pipeline.

According to the lawsuit, defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of its Long Island City ("LIC") property. In particular, Alexandria Real Estate's claims and confidence about the leasing value of the LIC property as a life-science destination. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Alexandria Real Estate Equities class action, go to https://rosenlegal.com/submit-form/?case_id=48531 call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.

SummaryTurkey isn’t the only thing making investors tired this Thanksgiving: AI fatigue is setting in as bubble fears rise and tech trades at dot-com era multiples.Record AI spending continues despite skepticism over near-term payoffs and many firms reporting zero measurable returns.AI investment could reach $4 trillion by 2030, while tech leaders acknowledge the risk of irrational spending and the potential for a bubble to burst.SA Quant identified five Strong Buy stocks less exposed to AI bubble risk in industries like materials, energy, real estate, logistics, and healthcare.I am Steven Cress, Head of Quantitative Strategies at Seeking Alpha. I manage the quant ratings and factor grades on stocks and ETFs in Seeking Alpha Premium. I also lead Alpha Picks, which selects the two most attractive stocks to buy each month, and also determines when to sell them. frender/iStock via Getty Images

AI Bubble Fears On The Rise Fears of an AI bubble fueled volatility in recent weeks as big tech valuations stretched and Wall Street’s top executives warned of a market correction. The S&P 500’s AI-led rally sent prices to

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given that any particular security, portfolio, transaction or investment strategy is suitable for any specific person. The author is not advising you personally concerning the nature, potential, value or suitability of any particular security or other matter. You alone are solely responsible for determining whether any investment, security or strategy, or any product or service, is appropriate or suitable for you based on your investment objectives and personal and financial situation. Steven Cress is the Head of Quantitative Strategy at Seeking Alpha. Any views or opinions expressed herein may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.

Recommended For You

Tim Boyle, Columbia Sportswear Company chairman and CEO, joins 'Money Movers' to discuss the holiday shopping season expectations, state of the consumer, impact of tariffs, and more.

November 28, 2025 11:53 AM EST | Source: Royalties Inc.
Toronto, Ontario--(Newsfile Corp. - November 28, 2025) - Royalties Inc. (CSE: RI) (OTCID: ROYIF) (or "the Company") reports its results for the third quarter ended September 30, 2025.

This news release should be read in conjunction with the Company's unaudited financial statements and the associated management's discussion and analysis (MD&A) for the quarter ended September 30, 2025 which are available on the Company's website at www.royaltiesinc.com or under the Company's profile on SEDAR+ at www.SEDARplus.ca.

In the third quarter of 2025, the Company generated revenue of $41,240 (+60%), consisting of $36,150 in dividend income from its increased investment in Music Royalties Inc. ("MRI") and $5,090 in other royalty income. Operating expenses totaled $111,727 (+130%), due to the expenses of the OTC US listing, legal expenses and increased marketing commensurate with the success in the lawsuit against Capstone Copper, leading to an operating loss of $70,487 versus $22,875 in the prior year's quarter. A non-cash foreign exchange loss of $62,273 on a US$2 million denominated contingent liability of a Mexico subsidiary resulted in a net loss of $132,760 for the quarter, compared with a net loss of $31,454 in Q3 2024. For the nine-month period, the Company had a net loss of $54,584 versus a loss of $118,762 in the prior year.

As at September 30, 2025, total assets increased to $2.775 million (December 31, 2024 - $1.25 million), reflecting the Company's increased investment in MRI of $1,525,000, for a total of $2,525,000 which will generate $181,800 in dividend income per year.

Ownership of 2% NSR on Capstone's Cozamin Mine Confirmed by Zacatecas Appeals Court

Royalties Inc.'s 88% subsidiary Minera Portree de Zacatecas ("MPZ") achieved a significant legal victory in Mexico on June 16, 2025 when it obtained a favourable court judgment confirming its entitlement to a 2% net smelter royalty ("NSR") on five concessions ("Portree claims") at Capstone Copper's ("Capstone") Cozamin Mine. Capstone appealed and on November 4, 2025, the Civil Chamber of the Superior Tribunal of Justice of Zacatecas upheld MPZ's entitlement to royalties established in a January 11, 2002, mining contract and rejected the appeals filed by defendants Raúl González Anaya and Capstone Gold S.A. de C.V. - the Appellate Court concluded that the defendants had improperly transferred the royalties without authorization. The next step is the calculation and the collection of the amount owed on the 2% NSR on past production from the Portree claim under the tailings pond. The accuracy of this amount will only be determined with the co-operation of Capstone, which has not been forthcoming. However, based on Capstone's public disclosures including its 43-101 reports and royalties paid in its audited financial statements, it is possible to estimate a figure of US$9 million for the amount owing before interest and damages.

Capstone initially reported that mining started within the Portree claim in the fourth quarter of 2019 which equates to 6 years of production. The company estimates that Portree represents up to 30% of the Mala Noche Footwall Zone ("MNFZ") based on the assumption of the proportion of the surface linear strike of 1.5 km of the MNFZ, the area which has represented almost all of the production at the Cozamin Mine since 2017, according to Capstone.

In 2024, Capstone paid US$4.4 million in royalties on US$234 million of net revenues for an average 1.9% NSR paid to two royalty holders. Royalties of US$1.2 million were paid to Gold Royalty Corporation ("GROY") in respect of a 1% NSR on 2 claims only 300 meters and down strike from the Portree claim on the MNFZ. Royalties of US$3.2 million were paid to Grupo Minera Bacis S.A. de C.V. ("Bacis"), the former owner of the Cozamin Mine, under the terms of a December 2003 agreement where a 3% NSR is paid on production from the property covered by the agreement. However, based on Capstone's 43-101 and numerous public documents, MPZ estimates that the Bacis area has long since been substantially mined out and therefore Capstone has incorrectly paid Bacis, royalties due to MPZ. Accordingly, the 2% NSR equates to approximately US$1.5 million per year on the production since 2019 for a total estimated US$9 million amount owing to MPZ.

In addition, the actual value of the 2% NSR includes the future production under the current mine plan to 2030 plus the depth potential and any resource mined on the remaining 90% of the area covered by the five Portree claims which is yet to be exploited. This includes the historical high grade Parroquia copper mine in the southwest of current mine operations with an estimated 2 million tonnes historical resource. MPZ hired a local geological expert who reviewed Capstone's public 2019-2020 drill results on the Portree claim and estimated the value of the 2% NSR at US$25 million. With the ongoing rise in copper and especially with record silver prices, the value of the 2% NSR will continue to appreciate for the foreseeable future.

"The second legal victory against Capstone in Mexico, which has clearly lost twice in court in a simple open and shut case, should finally bring its Management and Directors to their senses to step up and resolve this unnecessary dispute. Unfortunately, they have been relying on the bad advice of a Mexican lawyer who is documented lying in front of the judge. We are committed to using all means at our disposal to exact accountability and settlement, including the seizing of assets which will involve the police. This is an immaterial claim to Capstone and should be dealt with accordingly," commented Tim Gallagher, Chairman and CEO.

About Royalties Inc.

Royalties Inc. owns a 100% interest, subject to a 1.5% NSR owned as a separate asset, on the Bilbao silver-zinc-lead project located in the State of Zacatecas, Mexico.Royalties Inc. owns 88% of the outstanding shares of Minera Portree de Zacatecas, S.A. de C.V ("MPZ") which holds a court confirmed claim (twice) to a 2% net smelter royalty established in 2002 on five mining concessions called the 'Portree claims', a portion of which is on the Mala Noche Footwall Zone, the main source of production at the Cozamin mine where Capstone Copper Corp. ("Capstone") has been mining since 2010. Capstone attempted to assign this royalty to themselves without the knowledge, consent or proper payment to MPZ, the longstanding and rightful owner since 2002. Royalties Inc. has a 5% stake in Music Royalties Inc. ("MRI"), which has paid out over $13 million in 70 monthly dividends since 2019 from 31 cash-flowing catalogs with 7,000 songs with a 7.2% annual yield. Neither the CSE, nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this press release.

Forward-Looking Statements

This news release contains "forward-looking information" within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as "may", "will", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of those terms, or other similar words, expressions, and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen, or by discussions of strategy. Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected or implied by such forward-looking statements. Such risks include, but are not limited to: sufficient capital and financing required in order to fulfill the Company's business plans and strategy may not be obtained as expected; that the Company will not be able to pay future dividends; and other risks related to the Company as disclosed in the documents filed on the Company's profile at SEDAR+ at www.SEDARplus.ca. Accordingly, readers are cautioned not to place undue reliance on forward-looking statements contained in this press release and they are expressly qualified in their entirety by this cautionary statement. The forward-looking statements herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. The Company does not undertake any obligation to update publicly or revise any such forward-looking statements whether as a result of new information, future events or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276267

Key Takeaways ANIP is seeing sharp rare-disease growth driven by Cortrophin Gel and steady generics performance.Cortrophin Gel sales are up 70% YTD and projected to rise 75-78% for 2025, offsetting softness elsewhere.AMRX benefits from diversified segments, though generics pricing pressure and mixed specialty trends persist.
ANI Pharmaceuticals (ANIP - Free Report) and Amneal Pharmaceuticals (AMRX - Free Report) are both generic drugmakers, but their overall business models differ.

ANIP’s operations are split between rare disease therapies and generics, with specialty growth led by Cortrophin Gel. On the other hand, AMRX runs a broader three-segment structure, giving it a mix of generics scale, specialty products and government-channel distribution.

But which one makes for a better investment pick today? Let's examine the fundamentals of the two stocks to make a prudent choice.

The Case for ANIPANI Pharmaceuticals has demonstrated a solid financial performance so far this year, driven by steady growth across its rare disease and generics portfolios.

Though sales are divided equally between the two segments, ANIP’s rare disease business clearly stands out as the primary driver of momentum. In the first nine months of 2025, sales from this segment have more than doubled compared with the year-ago period. Much of this strength comes from the ACTH-based injection Cortrophin Gel, which has become the centerpiece of the company’s specialty strategy. So far this year, the drug has added $236 million to the company’s top line — up 70% year over year — supported by broader adoption across neurology, rheumatology, nephrology and ophthalmology.

This momentum in Cortrophin Gel is likely to continue, supported by new clinical studies (including a phase IV study in acute gouty arthritis) and ongoing efforts to deepen specialty penetration. For the full year 2025, ANI Pharmaceuticals expects this product’s sales to be between $347 million and $352 million, reflecting a 75-78% increase over the prior year.

The growth in Cortrophin Gel sales also helps offset the softness in the ophthalmology products Iluvien and Yutiq, which have been facing reimbursement and access challenges. While near-term expectations for these therapies have been lowered, ANIP is taking steps to expand coverage, strengthen its field force and tap into a much larger eligible patient population. Driven by these factors, ANI Pharmaceuticals expects a rebound in sales growth for both drugs in 2026.

ANIP’s generics business also remains an important pillar of stability, driven by higher base-business volumes and contributions from new product launches. However, with new entrants expected to enter the market in Q4, generics sales growth is likely to slow down in the coming quarters.

Competitive pressure is also building within the rare disease segment. The primary competitor to Cortrophin Gel is Acthar Gel, which is marketed by Keenova Therapeutics (formerly Mallinckrodt Pharmaceuticals). Like ANIP, Keenova has also been experiencing strong demand for Acthar Gel, recently raising its full-year 2025 sales growth outlook for Acthar Gel to 30-35%, up from the prior 20-30% range. This suggests that the competitive environment for ACTH-based therapies is intensifying.

The Case for AMRXAmneal Pharmaceuticals generates revenues from three primary businesses: Affordable Medicines, Specialty and AvKARE. This diversified structure gives the company a balanced mix of generics-led scale, specialty-driven margin potential and government-channel distribution stability. The company projects to close 2025 with revenues between $3.0 billion and $3.1 billion, implying  year-over-year growth of 7.5-11%.

Affordable Medicines — which includes retail generics, institutional products, injectables, biosimilars and international sales — remains the largest contributor. The segment continues to benefit from a broad portfolio across complex generics and injectable products, supported by ongoing launches and steady demand across key therapeutic categories. While generics remain a competitive space, Amneal’s scale and manufacturing footprint have helped sustain growth so far this year.

The Specialty segment provides a higher-value layer to the company’s revenue mix, anchored by central nervous system and endocrine therapies. While momentum from products like Crexont (for Parkinson’s disease) and Unithroid (for hypothyroidism) is driving this segment, we expect new products, like the recently launched Brekiya (for migraine), to further boost sales in the coming quarters.

AvKARE segment adds another dimension to Amneal’s business, serving the U.S. federal government, institutional buyers and the retail market through distribution agreements and government-label programs.

However, despite its diversified model, Amneal faces several headwinds. Pricing pressure in the generics market remains persistent, owing to intense competition and increased payer leverage as more biosimilars and competing generics enter the market. Sales of the Specialty segment have been negatively impacted by the falling sales of Rytarvy (for Parkinson’s disease), which lost exclusivity earlier this year. AvKARE is sensitive to procurement cycles and shifts in government contracting dynamics, which can introduce variability in its contribution.

How Do Estimates Compare for ANIP & AMRX?The Zacks Consensus Estimate for ANIP’s 2025 sales implies year-over-year growth of nearly 42% while EPS estimates are expected to rise by 45%. Bottom-line estimates for both 2025 and 2026 have increased over the past 30 days.

Image Source: Zacks Investment Research

AMRX’s 2025 sales are expected to rise 8% year over year, while the bottom-line estimates are expected to increase by over 36%. EPS estimates for 2025 and 2026 have risen over the past 30 days.

Image Source: Zacks Investment Research

Price Performance and Valuation of ANIP & AMRXYear to date, shares of ANIP have surged 53%, while those of AMRX have soared 58%. In comparison, the industry has risen 20%, as seen in the chart below.

Image Source: Zacks Investment Research

From a valuation standpoint, Amneal Pharmaceuticals seems to be more expensive than ANI Pharmaceuticals, going by the price/earnings (P/E) ratio. ANIP’s shares currently trade at 12.67 times forward 12-month earnings, lower than 14.77 for AMRX.

Image Source: Zacks Investment Research

ANIP or AMRX: Which Is a Better Pick?While both companies remain financially robust with diversified operations, the sales momentum in ANI Pharmaceuticals’ business gives it an edge over Amneal Pharmaceuticals. This top-line strength is also translating into faster earnings growth compared with AMRX, which continues to face margin pressures across its generics and AvKARE businesses.

ANIP also trades at a more attractive valuation relative to AMRX, offering additional room for upside given its solid fundamentals and positive stock-price trajectory.

Also, ANI Pharmaceuticals sports a Zacks Rank #1 (Strong Buy) while Amneal Pharmaceuticals carries a Zacks Rank #3 (Hold). This further reinforces ANIP’s more favorable standing in the current investment landscape.

You can see the complete list of today’s Zacks #1 Rank stocks here.

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure

Crypto analyst Snow, who called the Bitcoin top, has declared that BTC will not reach $116,000 in the next year. He made this comment while downplaying the recent market recovery, claiming it was merely a dead-cat bounce. 

In an X post, Snow stated that the algorithm is printing a new ceiling, which is why Bitcoin will bounce, but that it will not breach $116,500 in the next 365 days. He further warned that this is simply a Dead Cat Bounce structure, which is why the analyst believes traders shouldn’t get their hopes up for sustained bullish momentum.  

Snow had rightly called the Bitcoin top, selling the flagship crypto when it was trading around its current all-time high (ATH) of $126,000. The analyst’s latest comment comes amid BTC’s rise above $90,000, which has provided optimism that the bull market may still be in play, with an extended market cycle a possibility. 

Source: Chart from Snow on X
However, the analyst asserted that the “Supercycle” narrative is a lie sold to market participants by those who need them to hold their bags. He also revealed that he is looking for shorts, not longs, as he still expects BTC to crash further. Crypto analyst Colin also recently suggested that the current market recovery is a Dead Cat bounce.

The analyst stated that there is an 80% chance that BTC is already in a bear market. Meanwhile, he noted that there is only a 20% chance the flagship crypto will hit a new all-time high on this bounce. However, Colin predicted that Bitcoin could reach between $100,000 and $115,000 on this recovery. 

BTC Rally About To Start
Crypto analyst Titan of Crypto indicated that Bitcoin is about to witness a rally that could see it break above the psychological $100,000 level. This came as he noted that a rally usually follows 10-day Stochastic RSI bullish crossovers. However, the analyst added that the real question is whether this rally will be strong enough to break the ATH or whether it is simply a Dead Cat bounce confirming the end of the bull market. 

The analyst had revealed that he is currently 80% bearish and 20% bullish. However, crypto analyst CrediBULL Crypto believes the bull market is still on as long as Bitcoin doesn’t drop below $74,000, which he highlighted as the key high-timeframe level. With the monthly close approaching, the analyst stated that a close above $93,000 would be a positive sign, while one above $102,000 would be “incredibly bullish.”

At the time of writing, the Bitcoin price is trading at around $91,450, up in the last 24 hours, according to data from CoinMarketCap.

BTC trading at $91,192 on the 1D chart | Source: BTCUSDT on Tradingview.com
Featured image from Pngtree, chart from Tradingview.com

Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.

Sign Up for Our Newsletter!
For updates and exclusive offers enter your email.

Scott Matherson is a leading crypto writer at Bitcoinist, who possesses a sharp analytical mind and a deep understanding of the digital currency landscape. Scott has earned a reputation for delivering thought-provoking and well-researched articles that resonate with both newcomers and seasoned crypto enthusiasts.
Outside of his writing, Scott is passionate about promoting crypto literacy and often works to educate the public on the potential of blockchain.

ETF 100% win rate is spoiled by the first day of negative multi-million dollar flows. Is BlackRock holding the wild card?

Puntos claves de la noticia:

Bitcoin trades at $92,693, targeting a breakout toward $97,000-$100,000.
On-chain data shows strong long-term holder accumulation and reduced selling.
U.S. Bitcoin ETFs see massive $1.5 billion weekly inflows from institutions.

The current price of Bitcoin (BTC) is around $92,693 USD, showing a +1.92% rise over the past 24 hours, with a market capitalization of $1.85 trillion and a 24-hour trading volume exceeding $50.6 billion. BTC continues to hold dominance over the cryptocurrency market, supported by a surge in institutional inflows and bullish derivatives positioning.

From a technical perspective, Bitcoin is trading above its short-term moving averages, with the 20-day EMA near $90,500 USD acting as immediate support and the next resistance target at $94,000 USD.

The RSI remains in a strong bullish range around 68 points, confirming positive momentum, while the MACD histogram continues expanding on the positive side, suggesting potential for a continued upward trend. Traders are now watching for a breakout above $93,800–$94,200, which could trigger acceleration toward $97,000 USD.

On-chain data further strengthens the bullish narrative. Metrics from Glassnode and CryptoQuant show that long-term holders (LTHs) have reduced their exchange deposits to the lowest levels since mid-2023, reflecting strong conviction and accumulation.

Source: Glassnode
The Realized Cap has reached a new record high above $550 billion, suggesting that capital inflows continue entering the network at higher price levels.

Source: Glassnode
Meanwhile, the supply last active over 1 year has reached 69.4%, reinforcing that investors are locking up BTC for the long term. Miner behavior remains stable, with the hashrate posting new all-time highs, signaling network security confidence ahead of the next halving event in April 2028.

On the fundamental side, Bitcoin’s upward momentum is driven by ETF inflows, macroeconomic stability, and increased global adoption. According to CoinMarketCap and recent reports from Bloomberg Crypto, the U.S. Bitcoin ETFs have experienced inflows exceeding $1.5 billion over the past week, primarily from institutional investors reallocating funds from traditional equity ETFs.

The European Central Bank’s latest monetary stance—which kept rates unchanged amid slowing inflation—has strengthened investor interest in digital assets as a hedge against long-term currency devaluation.

Recent Bitcoinnews highlights several key developments

The launch of a new Bitcoin futures ETF in Japan under the Osaka Digital Exchange has sparked Asian demand.

El Salvador announced its second Bitcoin bond issuance, attracting more than $600 million in pre-sale commitments.

A major update to the Lightning Network protocol has been successfully integrated, significantly improving transaction throughput and lowering fees—boosting real-world adoption potential.

Finally, institutional accumulation wallets continue to grow, with addresses holding over 1,000 BTC increasing by 3.8% in November, according to on-chain trackers.

Overall, Bitcoin’s technical and fundamental outlook remains robust. On-chain indicators point to accumulation and limited sell pressure, while macroeconomic and regulatory trends favor continued institutional participation. If BTC maintains support above $91,000 USD, the short-term projection targets $97,000–$100,000 USD by mid-December 2025. 

XRP continues to hold its ground near $2.22, moving far more steadily than Bitcoin, Ethereum, and other volatile altcoins this week. Despite the broader market’s turbulence, XRP price remains range-bound, neither breaking out nor breaking down. However, new updates from the Ripple ecosystem and fresh on-chain data provide important clues about what comes next. With DEX activity rising but payment flows shrinking, traders are questioning whether XRP is preparing for its next move or simply cooling off after recent gains.

Latest Ripple & XRPL UpdatesSeveral ecosystem developments have been noted recently:

Ripple continues expanding its tokenization and institutional settlement initiatives, with new corridor pilots reported this month.XRPL’s AMM adoption shows steady progress, supporting growing swap activity on the ledger.Development proposals around hooks and sidechains remain active, increasing network utility expectations.In broader discussions, Ripple leadership reiterated its focus on enterprise payments and compliance-aligned blockchain solutions.These updates reinforce network development even as near-term price stays muted.

On-Chain Metrics: What the Data ShowsXRP’s latest on-chain data reveals a mixed landscape, with strong ledger activity but weakening payment utility. While internal network operations remain healthy, broader transactional demand has cooled significantly, offering a clearer picture of what may drive XRP’s next major move.

Key On-Chain Metrics (Past Several Weeks)

XRPL DEX Transactions: ~954,000 daily, one of the highest recently.Payments Volume: Down ~90% since October.Active Accounts: Flat, showing no surge in new user activity.Total Transactions: Only ~8.9% growth recently, indicating moderate expansion.AMM usage: Increasing steadily as liquidity pools deepen across major pairs.This divergence shows that while XRPL is busy internally, outward-facing demand has softened.

XRP Price AnalysisXRP is trading above the $2.10 support, a key base that has held throughout November. A decisive push above $2.32could open the path toward $2.48, but indicators currently reflect a neutral bias. No major selling pressure is present, yet buyers are not aggressive either. If the price falls below $2.10, a deeper retest toward $1.96 becomes likely. For now, the structure favors sideways movement unless volume expands.

The daily timeframe suggests a range-bound consolidation, but the weekly chart reflects the rising bearish influence. The token has entered the Ichimoku cloud for the first time in 2025 which indicates that the uptrend is slowing down as the buyers are losing strength. It also indicates that the token is entering a consolidation phase or sideways movement. If it fails to hold inside the cloud, then the XRP price is feared for a deeper correction. However, the weekly RSI has triggered a bullish divergence that could outweigh the cloud’s weakness. 

It means momentum is turning bullish while price is still correcting inside the cloud.

What usually happens next:

Price stabilizes inside the cloud
A slow grind upward begins
A powerful macro breakout occurs if price exits above the cloud
This often leads to a strong trend reversal or multi-week rallyIn simple terms, the bullish reversal is brewing for the XRP price while the markets may remain consolidated. 

Conclusion: Can XRP Reach $3 Before the End of 2025?XRP’s current consolidation phase doesn’t signal immediate explosive growth, but its broader structure still supports a gradual uptrend. If XRPL development continues to expand and payment flows recover, a move toward $3 is achievable before the end of 2025. However, the path is likely to be slow and dependent on improved on-chain demand, regulatory clarity, and stronger market momentum. XRP remains positioned for long-term growth—but a sustained resurgence in utility will be the key catalyst for a $3 breakout.

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.

Crypto-related stocks are higher across the board, led by the bitcoin miners.

The ZEC "pump and dump" is over, Max Keiser claimed.

The cryptocurrency market rebounded substantially over the past week, but Zcash (ZEC) has not followed the overall green wave.

Instead, its price has plummeted by approximately 27% within that timeframe, and several analysts now predict it is poised for a much more substantial collapse.

Is the Bull Run Over?
Currently, ZEC trades at roughly $470, representing a solid retreat from the local high above $730 reached earlier this month. Recall that the asset was at the forefront of gains in October and most of November, but the bears seem to have regained control recently.

ZEC Price, Source: CoinGecko
While the native token of Zcash was the subject of very bullish price predictions during its bull run, the landscape has changed the analysts’ tone. X user Tryrex noted that ZEC has formed a triple top on its chart, claiming it “doesn’t look strong” and forecasting a plunge to around $350 in the following days.

Just a few hours ago, X user Altcoin Sherpa predicted that the asset’s valuation could plunge below $200 in the coming weeks or months, claiming some bounces might accompany the downtrend.

Max Keiser, the American broadcaster and financial commentator who is known as a devoted fan of Bitcoin, also chipped in. He believes the ZEC “pump and dump” is over, arguing that a crash to $55 “looks inevitable.” True to himself he concluded his post with the following:

“Bitcoin Only. Everything else is just gambling.”

The Bulls Haven’t Capitulated Yet
Despite the price pullback, some analysts still think ZEC isn’t done for this cycle. X user Altcoin Miyagi claimed the asset could soar to $1,000: a prediction that aligns with the one made by Arthur Hayes.

You may also like:

Bitcoin Unable to Sustain Above $110K, Zcash (ZEC) Pumps by 10%: Market Watch

Bitcoin (BTC) Dips Below $122K, ZCash (ZEC) Explodes by 35%: Market Watch

ZEC Skyrockets as Grayscale Sparks Frenzy: Big Money Addresses Cross $10M

Initially, the co-founder of BitMEX envisioned a price explosion to $10,000, but later revised the target to the aforementioned $1K. Interestingly, Hayes recently offloaded some of his altcoin bags, but ZEC was not included in the sell-off.

Grayscale’s intention to convert its Zcash Trust into an ETF supports the bullish thesis. The launch of such a product will allow investors to gain exposure to the asset without having to worry about safeguarding it, and could boost interest.

Meanwhile, ZEC’s Relative Strength Index has dropped to almost 30, thus nearing overbought zone and suggesting the valuation might rebound in the near future. The technical analysis tool measures the speed and magnitude of recent price changes to give traders an idea of what comes next. It ranges from 0 to 100, and readings above 70 are considered bearish territory.

ZEC RSI, Source: RSI Hunter

Tags:

Fri, 28/11/2025 - 15:26

Shiba Inu's Shibarium blockchain now has a confirmed privacy roadmap by Zama, with its first major upgrade since the exploit that may set the stage for private SHIB transactions and confidential smart contract support in 2026.

Cover image via www.freepik.com

Shibarium just got a privacy-layer update that could change everything — and after this year's bridge hack, the timing could not be better. 

For those who have forgotten, on Sept. 12  the network endured a major exploit: a flash-loan attack plus a temporary validator key takeover drained some $4 million and forced a shutdown of the bridge.

Now the network built around Shiba Inu (SHIB) meme coin is heading toward full on-chain privacy built on homomorphic encryption. Once completed, that shift could finally address one of the biggest structural weaknesses exposed by the hack: transparent asset flow. 

HOT Stories

Zama → Shibarium Privacy upgrade incoming

That means that before the end of Q2 2026, we could finally get full on chain privacy and confidential smart contracts on Shibarium and Bone thanks to Zama’s Fully Homomorphic Encryption tech. pic.twitter.com/0uc4qNZ2co

— 𝐋𝐔𝐂𝐈𝐄 (@LucieSHIB) November 27, 2025 Should private smart contracts and private transactions go live, attackers will have far less visibility into on-chain positioning, reducing exploit opportunities.

Here's when Shibarium becomes privacy-enhancedActually, it is not even about Shibarium but about Zama’s public stack rollout schedule that leads with a mainnet launch in Q4, 2025, expansion to other EVM chains like Shibarium in early 2026, and a Solana rollout later that year. 

These plans place Shibarium squarely in the window for a privacy-enabled upgrade by Q2, 2026. Right now, the chain looks like a fast L2 built for memes like BONE or SHIB, but after upgrade, it may evolve into a serious infrastructure layer capable of supporting private DeFi, private execution, private value flow. 

You Might Also Like

If Shiba Inu's blockchain pulls off native FHE privacy support inside that window, it becomes one of the first consumer-ready ecosystems with real confidentiality baked in. 

After a hack that exposed the danger of bridge-based exploits, privacy could be the reset button the network badly needs.

Related articles

Solana secures 99% of tokenized equity volume as strong liquidity, negative funding, and structural patterns support further upside.

Izabela Anna2 min read

28 November 2025, 03:29 PM

Solana’s influence in the tokenized equities market continues to grow as the network secures more than 95% of monthly trading volume from July to October. The chain reached a peak of 99% in October, signaling a decisive shift in market preference toward faster settlement and cheaper execution.  Besides this dominance, new on-chain data shows rising investor confidence as activity strengthens across spot markets, derivatives flows, and long-term structural patterns. 

Solana’s rise reflects increased demand for tokenized assets on platforms such as xStocks and Dinari. These platforms continue to scale activity due to rapid settlement and low network fees, which remain crucial for high-volume equity products. Moreover, the broader RWA sector is expected to reach $16 trillion by 2030, placing Solana’s position in a favorable long-term trajectory.

Demand also shows in market performance. Solana trades near $142 as of press time, posting weekly gains above 12%. Additionally, liquidity stays deep as daily volume remains above $4 billion. This strength keeps investors engaged during broader market rotations.

Short Pressure Builds as Solana Reclaims Key LevelsJohnnyB, a crypto analyst, noted that Solana reclaimed the $140 range low while funding rates stayed negative. This combination signals aggressive short exposure during a recovery. Hence, traders monitor the $143–$145 range for signs of continuation. A break above this zone may send price toward $148.

Open interest also holds at elevated levels, showing strong positioning from both sides. However, sustained negative funding increases the chances of a short squeeze. Buyers only need to defend $139 on pullbacks to maintain control. Momentum then shifts higher as traders unwind short positions.

Long-Term Structure Points Toward Higher ExpansionSource: X

Another analyst moonbag tracks a larger multi-year cup-and-handle structure forming on higher time frames. Price continues to turn upward from the $120 to $135 accumulation area. A reclaim of $160 strengthens momentum toward $200. 

Meanwhile, the wider breakout level sits near $240. Clearing this region may unlock targets around $320, $380, and $450. Hence, analysts view every dip under $150 as strong long-term value.

ENRICH your inbox with our best storiesDon’t miss out and join our newsletter to get the latest,
well-curated news from the crypto world!

Izabela Anna

Izabela Anna is a knowledgeable freelance journalist, who boasts over five years of experience covering the cryptocurrency market. Her tenure has seen her navigate through the ebbs and flows of multiple market cycles, giving her a deep understanding within. Her journalistic focus lies in dissecting price action dynamics, scrutinizing the on-chain landscape, and providing insights from a technical perspective, making her a trusted voice in the realm of cryptocurrency reporting.

Read more about

Latest Solana (SOL) News Today

TL;DR The Avail Nexus mainnet was launched last week. It is a solution that promises a radical shift in how logic and assets move between blockchains. More than just a bridging tool, Nexus aspires to become Web3's execution backbone, making Avail's Nexus multichain execution as seamless as tapping a button.